Summary

The MRI systems market is shifting in terms of design and features, with helium-free and helium-light MRI technologies emerging as a significant growth driver. This development is largely influenced by increasing operational costs, helium supply instability, and the healthcare sector’s growing focus on sustainability. Conventional MRI systems typically require over 1,000 liters of helium to cool superconducting magnets. However, global helium shortages—such as the Helium Shortage 4.0 reported by Gasworld—have led to price increases of up to 250%, disrupting imaging operations and increasing maintenance costs. Such challenges are particularly pressing for mid-sized hospitals and outpatient facilities with constrained budgets. In response, manufacturers like Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), and Shanghai United Imaging Healthcare Co., Ltd. (China) have launched MRI systems that require significantly less helium or are completely sealed.

These innovations reduce the total cost of ownership and support environmental goals in terms of sustainability and zero carbon emissions.

The global MRI systems market is projected to reach USD 9.68 billion by 2031, growing from USD 6.88 billion in 2026 at a CAGR of 7.0% from 2026 to 2031.
The market’s growth can be attributed to an increase in disease burden, specifically for neurological and musculoskeletal conditions, which is expected to increase in the coming years. Additionally, an increase in the aging population, with the rising prevalence of chronic diseases such as cancer, is anticipated to increase the need for MRI systems across the globe. All these factors, on a broader level, will help to grow the market for MRI systems.

By field strength, the high & very high field segment dominated the MRI systems market in 2025.
The MRI systems market is categorized, by field strength, into low-to-mid-field MRI systems, high and very high field MRI systems, and ultra-high-field MRI systems. High and very high field MRI systems are known for their superior signal-to-noise ratio (SNR), which enhances clinical utility significantly. These systems are not only instrumental in imaging the brain, musculoskeletal structures, and vascular systems but also excel in specialized applications within psychiatry, neurology, biomedical research, and the early identification of conditions such as multiple sclerosis. The integration of MRI with complementary modalities such as PET and ultrasound further optimizes operational throughput and decreases helium usage while also delivering faster scan times and enhanced image resolution. High-field MRI systems, specifically those operating at 1.5T and 3T, are favored over low-field systems (below 1T) due to their markedly superior image quality, reduced acquisition times, and extensive range of clinical applications. The elevated SNR in high-field systems translates to clearer, more detailed imaging essential for diagnosing complex conditions such as neurological disorders, musculoskeletal injuries, and cardiovascular abnormalities. The rapid scan capabilities not only improve patient throughput but also enhance operational efficiency within healthcare facilities. Collectively, these factors have driven the growing adoption of high-field MRI systems within the market.

By architecture, the closed MRI systems segment accounted for the largest share of the market in 2025.
A closed MRI scanner utilizes a small cylindrical chamber to produce highly detailed images of the body’s structure. Most high-field superconducting magnetic resonance imaging scanners are designed in a closed format. Due to their higher efficiency, superior image quality, and increased throughput—all resulting from greater magnetic field strengths—closed MRI systems are considered the industry standard. In contrast to open MRI systems, which may require up to four or five scans for a comparable evaluation, closed MRI systems typically complete the scanning process in just one or two scans. This efficiency not only shortens examination times but also enhances the clinical utility of procedures and therapies. Closed MRI offers faster scan times, which helps reduce motion artifacts and improves patient throughput, making it particularly suitable for high-volume hospitals and diagnostic centers. Additionally, it supports advanced imaging techniques such as functional MRI (fMRI), diffusion-weighted imaging (DWI), and cardiac MRI, all of which rely on high-field strength for precision.

By design, the fixed/stationary MRI systems segment accounted for the largest share in 2025.
By design, the MRI systems market is divided into fixed/stationary MRI systems and portable MRI systems. Fixed MRI systems are generally preferred over portable ones for several reasons. They offer superior image quality, the ability to conduct full-body scans, improved workflow efficiency, and better long-term cost-effectiveness. Typically, fixed MRI units operate at a magnetic field. Another significant advantage of fixed MRI systems is their capability for full-body imaging, which further fuels market growth.

By application, the brain & neurological MRI segment is expected to register the highest growth rate during the forecast period.
By application, the MRI systems market is segmented into brain & neurological MRI, spine & musculoskeletal MRI, pelvic & abdominal MRI, vascular MRI, breast MRI, cardiac MRI, pediatric MRI, and other applications. The brain & neurological MRI segment of the MRI systems segment is expected to register the highest growth rate during the forecast period. Key drivers contributing to the rapid growth of this segment include the integration of sophisticated AI technologies as well as the increasing adoption of innovative devices that enable accurate targeting of internal organs, thereby facilitating real-time imaging capabilities.

By end user, the hospitals segment accounted for the largest share of the market in 2025.
By end user, the global MRI systems market is categorized into hospitals, diagnostic imaging centers, and other categories. In 2025, the hospitals segment accounted for the largest market share. This dominance is primarily due to the increased use of advanced MRI systems in hospitals, which enhance accurate diagnosis and raise awareness of the importance of early detection. Additionally, factors such as product launches, the growing adoption of advanced systems with improved features that support patient care, and a rising number of imaging procedures conducted in hospitals are also driving the growth of the market. As the demand for rapid and precise diagnoses of various medical conditions grows, many hospitals are prioritizing the installation of advanced MRI systems. Large government hospitals with dedicated imaging units have been early adopters of these technologies, while private hospitals are increasingly embracing advanced imaging solutions over time. The trend towards modernizing imaging workflows has further driven the adoption of MRI systems in hospitals.

Asia Pacific is expected to exhibit the highest growth rate in the MRI systems market.
The MRI systems market spans five primary regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Notably, the Asia Pacific region houses a significant number of MRI systems manufacturers that deliver a comprehensive range of MRI modalities equipped with advanced technological features, all while maintaining competitive pricing. End users, particularly in healthcare institutions, are increasingly facing budget constraints exacerbated by recent tariff sanctions; this has prompted a shift towards more cost-effective MRI solutions offered by Chinese manufacturers. The region's manufacturing landscape benefits from low labor costs and abundant resources, facilitating efficient production processes for MRI systems. These dynamics position the Asia Pacific market to experience the highest growth rate within the global landscape, driven by both increased local demand and the strategic pricing of offerings.

A breakdown of the primary participants referred to for this report is provided below:
・ By Company Type: Tier 1 - 30%; Tier 2 - 40%; and Tier 3 - 30%
・ By Designation: Directors - 10%; Managers - 30%; and Others - 60%
・ By Region: Asia Pacific - 45%; Europe - 22%; North America - 22%; RoW - 11%

The key players profiled in the MRI systems market include Siemens Healthineers (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan), Canon Inc. (Japan), Fonar Corporation (US), Esaote S.p.A (Italy), Shanghai United Imaging Healthcare Co., Ltd (China), Aspect Imaging Ltd. (US), and Time Medical Holding (Hong Kong).

Research Coverage
The research report examines the MRI systems market field strength, architecture, design, application, end user, and region. This research covers factors that are driving market expansion, analyzes prospects and parameters faced by industries in the present time, and provides specifics on the competitive landscape, considering market leaders and small and medium enterprises. This research also estimates the revenue of different market segments by considering five regions and micro-market analysis
Reasons to Buy the Report
The report will provide market leaders and new entrants with valuable information regarding the revenue estimates for the overall MRI systems market and its subsegments. It will help stakeholders understand the competitive landscape, allowing them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into the market dynamics, including key drivers, restraints, challenges, and opportunities.

This report provides insightful data on the following pointers:
・ Analysis of key drivers (Public-private partnerships to scale diagnostic imaging landscape, integration of iMRI into surgery to catalyze growth of MRI systems market, growing prevalence of MSDs and increasing geriatric population to increase demand), restraints (Complex operation and maintenance of MRI systems, global shortage of helium), opportunities (Emergence of helium-free MRI systems, expansion of pediatric MRI use cases, AI integration with MRI technology for process optimization), challenges (Limited capital budgets, dearth of trained and skilled professionals)
・ Market Penetration: In-depth coverage of product portfolios offered by the top players in the MRI systems market
・ Product Development/Innovation: In-depth coverage of product portfolios offered by the top players in the MRI systems market
・ Market Development: Insightful data on profitable developing areas
・ Market Diversification: Details about recent developments and advancements in the MRI systems market
・ Competitive Assessment: Extensive assessment of the products, growth tactics, revenue projections, and market categories of the top competitors

ページTOPに戻る

Table of Contents

1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.3 STUDY SCOPE 25
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 25
1.3.2 INCLUSIONS & EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 26
1.4 CURRENCY CONSIDERED 26
1.5 RESEARCH LIMITATIONS 27
1.6 STAKEHOLDERS 27
1.7 SUMMARY OF CHANGES 28
2 EXECUTIVE SUMMARY 29
2.1 MARKET HIGHLIGHTS & KEY INSIGHTS 29
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 30
2.3 DISRUPTIVE TRENDS IN MRI SYSTEMS MARKET 31
2.4 HIGH GROWTH SEGMENTS 32
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 33
3 PREMIUM INSIGHTS 34
3.1 MRI SYSTEMS MARKET OVERVIEW 34
3.2 ASIA PACIFIC MRI SYSTEMS MARKET, BY END USER AND COUNTRY 35
3.3 MRI SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 36
4 MARKET OVERVIEW 37
4.1 INTRODUCTION 37
4.2 MARKET DYNAMICS 37
4.2.1 DRIVERS 38
4.2.1.1 Public-private partnerships to scale diagnostic imaging landscape 38
4.2.1.2 Growing prevalence of MSDs and increasing geriatric population 38
4.2.1.3 Integration of iMRI into surgery 39
4.2.2 RESTRAINTS 39
4.2.2.1 Complex operation and maintenance of MRI systems 39
4.2.2.2 Global helium shortage 40
4.2.3 OPPORTUNITIES 40
4.2.3.1 Emergence of helium-free MRI systems 40
4.2.3.2 Expansion of pediatric MRI use cases 41
4.2.3.3 AI integration with MRI technology for process optimization 41
 
4.2.4 CHALLENGES 42
4.2.4.1 Limited capital budgets 42
4.2.4.2 Dearth of trained and skilled professionals 42
4.3 UNMET NEEDS 43
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 43
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 44
4.5.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MRI SYSTEMS MARKET 44
5 INDUSTRY TRENDS 46
5.1 PORTER’S FIVE FORCES ANALYSIS 46
5.1.1 BARGAINING POWER OF BUYERS 47
5.1.2 BARGAINING POWER OF SUPPLIERS 47
5.1.3 THREAT OF NEW ENTRANTS 47
5.1.4 THREAT OF SUBSTITUTES 47
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 48
5.2 MACROECONOMIC INDICATORS 48
5.2.1 INTRODUCTION 48
5.2.2 GDP TRENDS AND FORECAST 48
5.2.3 TRENDS IN DIAGNOSTIC IMAGING INDUSTRY 48
5.3 SUPPLY CHAIN ANALYSIS 49
5.3.1 PROMINENT COMPANIES 49
5.3.2 SMALL & MEDIUM-SIZED ENTERPRISES 49
5.3.3 DISTRIBUTION/DISTRIBUTOR 49
5.3.4 END USERS 49
5.4 VALUE CHAIN ANALYSIS 50
5.4.1 RESEARCH & PRODUCT DEVELOPMENT 50
5.4.2 RAW MATERIAL PROCUREMENT 50
5.4.3 MANUFACTURING 51
5.4.4 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 51
5.5 ECOSYSTEM ANALYSIS 51
5.6 PRICING ANALYSIS 52
5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023–2025 52
5.6.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 54
5.7 TRADE ANALYSIS 56
5.7.1 IMPORT DATA (HS CODE 901813) 56
5.7.2 EXPORT DATA (HS CODE 901813) 57
5.8 KEY CONFERENCES AND EVENTS, 2026–2027 58
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 58
5.10 INVESTMENT AND FUNDING SCENARIO 59
5.11 CASE STUDY ANALYSIS 61
 
5.12 IMPACT OF 2025 US TARIFF – MRI SYSTEMS MARKET 63
5.12.1 INTRODUCTION 63
5.12.2 KEY TARIFF RATES 63
5.12.3 KEY TARIFF RATES 63
5.12.4 PRICE IMPACT ANALYSIS 63
5.12.5 IMPACT ON COUNTRIES/REGIONS 64
5.12.5.1 US 64
5.12.5.2 Europe 64
5.12.5.3 Asia Pacific 64
5.12.6 IMPACT ON END-USE INDUSTRIES 64
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 65
6.1 KEY EMERGING TECHNOLOGIES 65
6.1.1 ARTIFICIAL INTELLIGENCE–DRIVEN IMAGE RECONSTRUCTION AND DIAGNOSTIC ASSISTANCE 65
6.1.2 ULTRA-LOW-FIELD AND PORTABLE MRI PLATFORMS 65
6.2 COMPLEMENTARY TECHNOLOGIES 66
6.2.1 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) AND HEALTH INFORMATION SYSTEM INTEGRATION 66
6.2.2 SIMULTANEOUS MULTI-SLICE AND ADVANCED PARALLEL IMAGING ACCELERATION 66
6.3 ADJACENT TECHNOLOGIES 66
6.3.1 MRI-COMPATIBLE INTERVENTIONAL AND SURGICAL NAVIGATION TECHNOLOGIES 66
6.4 PATENT ANALYSIS 67
6.5 IMPACT OF AI ON MRI SYSTEMS MARKET 68
6.5.1 TOP USE CASES AND MARKET POTENTIAL 68
6.5.2 KEY COMPANIES IMPLEMENTING AI 69
6.5.3 BEST PRACTICES IN MRI SYSTEMS MARKET 69
6.5.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 69
6.5.5 CLIENTS' READINESS TO ADOPT AI IN MRI SYSTEMS 70
6.6 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 70
6.7 REGULATORY LANDSCAPE 70
6.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
6.7.2 REGULATIONS, BY REGION 72
6.7.2.1 North America 72
6.7.2.1.1 US 72
6.7.2.1.2 Canada 73
6.7.2.2 Europe 73
 
6.7.2.3 Asia Pacific 74
6.7.2.3.1 Japan 74
6.7.2.3.2 China 75
6.7.2.3.3 India 76
6.8 REIMBURSEMENT SCENARIO ANALYSIS 77
6.8.1 RELEVANT REIMBURSEMENT CODE, BY COUNTRY 77
6.8.2 REIMBURSEMENT TRENDS, BY REGION, 2023–2025 79
6.8.2.1 North America 79
6.8.2.2 Europe 80
6.8.2.3 Asia Pacific 81
6.8.2.4 Latin America 81
6.8.2.5 Middle East & Africa 82
7 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 83
7.1 DECISION-MAKING PROCESS 83
7.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 83
7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 84
7.2.2 BUYING CRITERIA 84
7.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 85
7.4 UNMET NEEDS OF VARIOUS END-USE INDUSTRIES 86
7.5 MARKET PROFITABILITY 86
8 MRI SYSTEMS MARKET, BY APPLICATION 87
8.1 INTRODUCTION 88
8.2 BRAIN & NEUROLOGICAL MRI 88
8.2.1 NEW THERAPIES AND GUIDELINES TO ENHANCE DEMAND FOR MRI SYSTEMS 88
8.3 SPINE & MUSCULOSKELETAL MRI 89
8.3.1 GROWING PREVALENCE OF MUSCULOSKELETAL DISORDERS TO DRIVE MARKET 89
8.4 VASCULAR MRI 90
8.4.1 USE OF VASCULAR MRI AS ALTERNATIVE TO CT TO SUPPORT MARKET GROWTH 90
8.5 PELVIC & ABDOMINAL MRI 91
8.5.1 NEED FOR DETECTING PROSTATE AND CERVICAL CANCERS TO PROPEL MARKET 91
8.6 BREAST MRI 92
8.6.1 GROWING AWARENESS OF EARLY CANCER SCREENING TO DRIVE MARKET GROWTH 92
8.7 CARDIAC MRI 93
8.7.1 UPDATED MEDICAL GUIDELINES FOR CARDIAC THERAPY PLANNING TO DRIVE MARKET GROWTH 93
8.8 PEDIATRIC MRI 94
8.8.1 NEED FOR EFFICIENT DIAGNOSTIC ACCURACY AND EARLY DETECTION TO PROMOTE USE OF PEDIATRIC MRI 94
8.9 OTHER APPLICATIONS 95
9 MRI SYSTEMS MARKET, BY ARCHITECTURE 96
9.1 INTRODUCTION 97
9.2 CLOSED MRI SYSTEMS 97
9.2.1 STANDARD BORE MRI SYSTEMS 99
9.2.1.1 High accuracy and sensitivity of systems to propel market 99
9.2.2 WIDE-BORE MRI SYSTEMS 99
9.2.2.1 High-quality images and improved patient comfort to drive market 99
9.3 OPEN MRI SYSTEMS 100
9.3.1 USE FOR CHILDREN AND OBESE PATIENTS TO DRIVE MARKET 100
10 MRI SYSTEMS MARKET, BY DESIGN 102
10.1 INTRODUCTION 103
10.2 FIXED/STATIONARY MRI SYSTEMS 103
10.2.1 FLOOR-FIXED MRI SYSTEMS 104
10.2.1.1 High flexibility and low initial installation costs to drive demand 104
10.2.2 CEILING-FIXED MRI SYSTEMS 105
10.2.2.1 Need for MRI systems with high stability and more space to
drive market 105
10.3 PORTABLE MRI SYSTEMS 106
10.3.1 PROTOCOLIZED ADOPTION OF PORTABLE MRI SYSTEMS TO DRIVE
MARKET GROWTH 106
11 MRI SYSTEMS MARKET, BY END USER 108
11.1 INTRODUCTION 109
11.2 HOSPITALS 109
11.2.1 UPDATES IN DIAGNOSTIC IMAGING GUIDELINES TO PROPEL
MARKET GROWTH 109
11.3 DIAGNOSTIC IMAGING CENTERS 111
11.3.1 INCREASED PRIVATE IMAGING CENTERS AND SHIFT TOWARD OUTPATIENT FACILITIES TO DRIVE MARKET GROWTH 111
11.4 OTHER END USERS 112
12 MRI SYSTEMS MARKET, BY FIELD STRENGTH 113
12.1 INTRODUCTION 114
12.2 HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS 115
12.2.1 1.5T 116
12.2.1.1 Rising use of 1.5T MRI systems for routine examinations to propel market 116
12.2.2 3T 116
12.2.2.1 Strong gradient profile and ease of use to drive market growth 116
 
12.3 LOW-TO-MID-FIELD MRI SYSTEMS 117
12.3.1 INCREASING NEED FOR LUNG AND CARDIAC IMAGING TO DRIVE
MARKET GROWTH 117
12.4 ULTRA-HIGH-FIELD MRI SYSTEMS 118
12.4.1 RISING INNOVATION AND DEEP RESEARCH TO DRIVE MARKET GROWTH 118
13 MRI SYSTEMS MARKET, BY REGION 120
13.1 INTRODUCTION 121
13.2 NORTH AMERICA 121
13.2.1 US 124
13.2.1.1 Increased diagnostic imaging utilization and strategic reimbursement reforms to drive market growth 124
13.2.2 CANADA 125
13.2.2.1 Progressive government policies and growing pulse of diagnostic imaging to spur market 125
13.3 EUROPE 126
13.3.1 GERMANY 128
13.3.1.1 Digital push in healthcare access and shift toward outpatient/clinic settings to drive market growth 128
13.3.2 UK 129
13.3.2.1 Strong policy push for community diagnostic centers and capacity expansion to drive market growth 129
13.3.3 FRANCE 130
13.3.3.1 Increasing patient population and reforms in MRI coverage policies to boost growth 130
13.3.4 ITALY 131
13.3.4.1 EU-funded hospital upgrades to increase capital expenditure ability 131
13.3.5 SPAIN 132
13.3.5.1 Strategic policy reforms and increased MRI scans from private hospital chains to grow market 132
13.3.6 REST OF EUROPE 133
13.4 ASIA PACIFIC 133
13.4.1 JAPAN 136
13.4.1.1 Nationwide diagnostic imaging coverage plans and supportive government reimbursement policies to boost growth 136
13.4.2 CHINA 137
13.4.2.1 Foreign collaborations and strong demand from public healthcare facilities to drive market growth 137
13.4.3 INDIA 138
13.4.3.1 Strong public-private partnerships to propel market 138
13.4.4 AUSTRALIA 139
13.4.4.1 New research initiatives and policy enhancements to promote growth 139
13.4.5 SOUTH KOREA 140
13.4.5.1 Supportive government policies to promote growth 140
13.4.6 REST OF ASIA PACIFIC 140
13.5 LATIN AMERICA 141
13.5.1 BRAZIL 143
13.5.1.1 Increasing disease burden and growing adoption of healthcare insurance to drive market 143
13.5.2 MEXICO 144
13.5.2.1 Industry partnerships to drive market growth 144
13.5.3 REST OF LATIN AMERICA 145
13.6 MIDDLE EAST & AFRICA 146
13.6.1 GCC COUNTRIES 148
13.6.1.1 Favorable government initiatives to contribute to market growth 148
13.6.2 REST OF MIDDLE EAST & AFRICA 149
13.6.2.1 Increased adoption of MRI systems to contribute to growth 149
14 COMPETITIVE LANDSCAPE 150
14.1 INTRODUCTION 150
14.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023–2026 150
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MRI SYSTEMS MARKET 151
14.3 REVENUE ANALYSIS, 2021–2025 152
14.4 MARKET SHARE ANALYSIS, 2025 153
14.4.1 MARKET RANKING OF KEY PLAYERS, 2025 155
14.5 COMPANY VALUATION AND FINANCIAL METRICS 156
14.5.1 FINANCIAL METRICS 156
14.5.2 COMPANY VALUATION 156
14.6 BRAND/PRODUCT COMPARISON 157
14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 158
14.7.1 STARS 158
14.7.2 EMERGING LEADERS 158
14.7.3 PERVASIVE PLAYERS 158
14.7.4 PARTICIPANTS 158
14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 160
14.7.5.1 Company footprint 160
14.7.5.2 Region footprint 161
14.7.5.3 Field strength footprint 161
14.7.5.4 Application footprint 162
14.7.5.5 End user footprint 163
14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 164
14.8.1 PROGRESSIVE COMPANIES 164
14.8.2 RESPONSIVE COMPANIES 164
14.8.3 DYNAMIC COMPANIES 164
14.8.4 STARTING BLOCKS 164
 
14.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2025 166
14.8.5.1 Detailed list of key startups/SMEs 166
14.8.5.2 Competitive benchmarking of key startups/SMEs 167
14.9 COMPETITIVE SCENARIO 168
14.9.1 PRODUCT LAUNCHES 168
14.9.2 DEALS 169
14.9.3 EXPANSIONS 170
15 COMPANY PROFILES 171
15.1 KEY PLAYERS 171
15.1.1 SIEMENS HEALTHINEERS 171
15.1.1.1 Business overview 171
15.1.1.2 Products offered 172
15.1.1.3 Recent developments 173
15.1.1.3.1 Product launches 173
15.1.1.3.2 Deals 174
15.1.1.3.3 Expansions 175
15.1.1.4 MnM view 175
15.1.1.4.1 Right to win 175
15.1.1.4.2 Strategic choices 175
15.1.1.4.3 Weaknesses & competitive threats 175
15.1.2 KONINKLIJKE PHILIPS N.V. 176
15.1.2.1 Business overview 176
15.1.2.2 Products offered 177
15.1.2.3 Recent developments 178
15.1.2.3.1 Product launches 178
15.1.2.3.2 Deals 178
15.1.2.3.3 Expansions 179
15.1.2.4 MnM view 179
15.1.2.4.1 Right to win 179
15.1.2.4.2 Strategic choices 179
15.1.2.4.3 Weaknesses and competitive threats 179
15.1.3 GE HEALTHCARE 180
15.1.3.1 Business overview 180
15.1.3.2 Products offered 181
15.1.3.3 Recent developments 182
15.1.3.3.1 Product launches 182
15.1.3.3.2 Deals 182
15.1.3.3.3 Expansions 183
15.1.3.4 MnM view 183
15.1.3.4.1 Right to win 183
15.1.3.4.2 Strategic choices 183
15.1.3.4.3 Weaknesses & competitive threats 183
15.1.4 CANON MEDICAL SYSTEM 184
15.1.4.1 Business overview 184
15.1.4.2 Products offered 185
15.1.4.3 Recent developments 186
15.1.4.3.1 Product launches 186
15.1.4.3.2 Deals 186
15.1.4.4 MnM view 186
15.1.4.4.1 Right to win 186
15.1.4.4.2 Strategic choices 186
15.1.4.4.3 Weaknesses & competitive threats 187
15.1.5 FUJIFILM CORPORATION 188
15.1.5.1 Business overview 188
15.1.5.2 Products offered 189
15.1.5.3 Recent developments 190
15.1.5.3.1 Product launches 190
15.1.5.3.2 Deals 190
15.1.5.4 MnM view 190
15.1.5.4.1 Right to win 190
15.1.5.4.2 Strategic choices 191
15.1.5.4.3 Weaknesses & competitive threats 191
15.1.6 FONAR CORPORATION 192
15.1.6.1 Business overview 192
15.1.6.2 Products offered 193
15.1.6.3 Recent developments 193
15.1.6.3.1 Deals 193
15.1.7 ESAOTE S.P.A 194
15.1.7.1 Business overview 194
15.1.7.2 Products offered 194
15.1.7.3 Recent developments 195
15.1.7.3.1 Product launches 195
15.1.7.3.2 Deals 195
15.1.8 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. 196
15.1.8.1 Business overview 196
15.1.8.2 Products offered 197
15.1.8.3 Recent developments 197
15.1.8.3.1 Product launches and approvals 197
15.1.8.3.2 Deals 198
15.1.8.3.3 Expansions 198
15.1.9 ASPECT IMAGING LTD. 199
15.1.9.1 Business overview 199
15.1.9.2 Products offered 199
15.1.10 TIME MEDICAL HOLDING 200
15.1.10.1 Business overview 200
15.1.10.2 Products offered 200
15.1.10.3 Recent developments 201
15.1.10.3.1 Product launches and approvals 201
15.1.10.3.2 Expansions 201
15.1.11 NEUSOFT MEDICAL SYSTEMS CO., LTD. 202
15.1.11.1 Business overview 202
15.1.11.2 Products offered 202
15.1.11.3 Recent developments 202
15.1.11.3.1 Deals 202
15.1.12 STERNMED GMBH 203
15.1.12.1 Business overview 203
15.1.12.2 Products offered 203
15.1.12.3 Recent developments 203
15.1.12.3.1 Deals 203
15.1.13 HYPERFINE, INC. 204
15.1.13.1 Business overview 204
15.1.13.2 Products offered 205
15.1.13.3 Recent developments 205
15.1.13.3.1 Product launches and approvals 205
15.1.13.3.2 Deals 205
15.1.14 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. 206
15.1.14.1 Business overview 206
15.1.14.2 Products offered 206
15.1.15 SHENZHEN ANKE HIGH-TECH., LTD. 207
15.1.15.1 Business overview 207
15.1.15.2 Products offered 207
15.2 OTHER PLAYERS 208
15.2.1 MAGNETICA LTD 208
15.2.2 AURORA HEALTHCARE US CORP 209
15.2.3 INNERVISION MRI LTD. 210
15.2.4 BEIJING WANDONG MEDICAL TECHNOLOGY CO., LTD. 211
15.2.5 MEDONICA CO., LTD 212
15.2.6 NEOSCAN SOLUTIONS GMBH 212
15.2.7 KANGDA INTERCONTINENTAL MEDICAL EQUIPMENT CO., LTD. 213
15.2.8 MINFOUND MEDICAL SYSTEMS CO., LTD. 214
15.2.9 SYNAPTIVE MEDICAL 215
15.2.10 XINGAOYI MEDICAL EQUIPMENT CO., LTD 215
 
16 RESEARCH METHODOLOGY 216
16.1 RESEARCH DATA 216
16.1.1 SECONDARY RESEARCH 217
16.1.1.1 Key secondary sources 218
16.1.1.2 Key data from secondary sources 218
16.1.1.3 Objectives of secondary research 219
16.1.2 PRIMARY RESEARCH 219
16.1.2.1 Key primary sources 220
16.1.2.2 Key supply- and demand-side participants 220
16.1.2.3 Breakdown of primary interviews 221
16.1.2.4 Objectives of primary research 221
16.1.2.5 Key primary insights 222
16.2 MARKET SIZE ESTIMATION 222
16.2.1 BOTTOM-UP APPROACH 223
16.2.1.1 Company revenue estimation 224
16.2.1.2 Customer-based market estimation 224
16.2.1.3 Primary interviews 225
16.2.2 TOP-DOWN APPROACH 226
16.3 GROWTH RATE ASSUMPTIONS 227
16.4 DATA TRIANGULATION 229
16.5 RESEARCH ASSUMPTIONS 230
16.6 RESEARCH LIMITATIONS 230
16.7 RISK ANALYSIS 231
17 APPENDIX 232
17.1 DISCUSSION GUIDE 232
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 237
17.3 CUSTOMIZATION OPTIONS 239
17.4 RELATED REPORTS 239
17.5 AUTHOR DETAILS 240

ページTOPに戻る

List of Tables/Graphs

TABLE 1 MRI SYSTEMS MARKET: UNMET NEEDS 43
TABLE 2 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN
THE MRI SYSTEMS MARKET 44
TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON MRI SYSTEMS MARKET 47
TABLE 4 AVERAGE SELLING PRICE OF MRI SYSTEMS, BY KEY PLAYER, 2023–2025 53
TABLE 5 AVERAGE SELLING PRICE OF MRI SYSTEMS, BY REGION, 2023–2025 55
TABLE 6 IMPORT DATA FOR MRI SYSTEMS, BY COUNTRY, 2021–2025 (USD THOUSAND) 56
TABLE 7 EXPORT DATA FOR MRI SYSTEMS, BY COUNTRY, 2021–2025 (USD THOUSAND) 57
TABLE 8 MRI SYSTEMS MARKET: LIST OF MAJOR CONFERENCES AND EVENTS
IN 2026–2027 58
TABLE 9 CASE STUDY 1: DEPLOYMENT OF WIDE-BORE 3T MRI SYSTEMS TO ENHANCE ONCOLOGICAL DIAGNOSTIC THROUGHPUT IN LARGE TERTIARY HOSPITAL NETWORK 61
TABLE 10 CASE STUDY 2: INTEGRATION OF AI-AUGMENTED 1.5T MRI SYSTEMS IN INDEPENDENT DIAGNOSTIC IMAGING CHAIN TO OPTIMIZE MUSCULOSKELETAL REPORTING EFFICIENCY 62
TABLE 11 US-ADJUSTED RECIPROCAL TARIFF RATES 63
TABLE 12 MRI SYSTEMS MARKET: KEY PATENTS, 2024–2026 68
TABLE 13 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 14 US FDA: MEDICAL DEVICE CLASSIFICATION 72
TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 73
TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 73
TABLE 17 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 74
TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES 75
TABLE 19 NORTH AMERICA: RELEVANT MRI REIMBURSEMENT CODE 77
TABLE 20 EUROPE: RELEVANT MRI REIMBURSEMENT CODE 78
TABLE 21 ASIA PACIFIC: RELEVANT MRI REIMBURSEMENT CODE 78
TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
TOP THREE END USERS (%) 84
TABLE 23 KEY BUYING CRITERIA FOR TOP THREE END USERS 85
TABLE 24 MRI SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 88
TABLE 25 BRAIN & NEUROLOGICAL MRI SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 89
TABLE 26 SPINE & MUSCULOSKELETAL MRI SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 90
TABLE 27 VASCULAR MRI SYSTEMS MARKET, BY REGION, 2024–2031(USD MILLION) 91
TABLE 28 PELVIC & ABDOMINAL MRI SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 92
TABLE 29 BREAST MRI SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 93
TABLE 30 CARDIAC MRI SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 94
TABLE 31 PEDIATRIC MRI SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 95
TABLE 32 OTHER APPLICATIONS: MRI SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 95
TABLE 33 MRI SYSTEMS MARKET, BY ARCHITECTURE, 2024–2031 (USD MILLION) 97
TABLE 34 CLOSED MRI SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 98
TABLE 35 CLOSED MRI SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 98
TABLE 36 STANDARD BORE MRI SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 99
TABLE 37 WIDE-BORE MRI SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 100
TABLE 38 OPEN MRI SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 101
TABLE 39 MRI SYSTEMS MARKET, BY DESIGN, 2024–2031 (USD MILLION) 103
TABLE 40 FIXED/STATIONARY MRI SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 104
TABLE 41 FIXED/STATIONARY MRI SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 104
TABLE 42 FLOOR-FIXED MRI SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 105
TABLE 43 CEILING-FIXED MRI SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 106
TABLE 44 PORTABLE MRI SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 107
TABLE 45 MRI SYSTEMS MARKET, BY END USER, 2024–2031 (USD MILLION) 109
TABLE 46 MRI SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2024–2031 (USD MILLION) 110
TABLE 47 MRI SYSTEMS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION,
2024–2031 (USD MILLION) 111
TABLE 48 MRI SYSTEMS MARKET FOR OTHER END USERS, BY REGION,
2024–2031 (USD MILLION) 112
TABLE 49 MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024–2031 (USD MILLION) 114
TABLE 50 MRI SYSTEMS MARKET, BY REGION, 2024–2026 (UNITS) 114
TABLE 51 HIGH-TO-VERY-HIGH-FIELD MRI SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 115
TABLE 52 1.5T MRI SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 116
TABLE 53 3T MRI SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 117
TABLE 54 LOW-TO-MID-FIELD MRI SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 118
TABLE 55 ULTRA-HIGH-FIELD MRI SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 119
TABLE 56 MRI SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 121
TABLE 57 NORTH AMERICA: MRI SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 122
TABLE 58 NORTH AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 123
TABLE 59 NORTH AMERICA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2024–2031 (USD MILLION) 123
TABLE 60 NORTH AMERICA: MRI SYSTEMS MARKET, BY DESIGN, 2024–2031 (USD MILLION) 123
TABLE 61 NORTH AMERICA: MRI SYSTEMS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 124
TABLE 62 NORTH AMERICA: MRI SYSTEMS MARKET, BY END USER,
2024–2031 (USD MILLION) 124
TABLE 63 US: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024–2031 (USD MILLION) 125
TABLE 64 CANADA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 126
TABLE 65 EUROPE: MRI SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 126
TABLE 66 EUROPE: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 127
TABLE 67 EUROPE: MRI SYSTEMS MARKET, BY ARCHITECTURE, 2024–2031 (USD MILLION) 127
TABLE 68 EUROPE: MRI SYSTEMS MARKET, BY DESIGN, 2024–2031 (USD MILLION) 127
TABLE 69 EUROPE: MRI SYSTEMS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 128
TABLE 70 EUROPE: MRI SYSTEMS MARKET, BY END USER, 2024–2031 (USD MILLION) 128
TABLE 71 GERMANY: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 129
TABLE 72 UK: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024–2031 (USD MILLION) 130
TABLE 73 FRANCE: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 130
TABLE 74 ITALY: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024–2031 (USD MILLION) 131
TABLE 75 SPAIN: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024–2031 (USD MILLION) 132
TABLE 76 REST OF EUROPE: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 133
TABLE 77 ASIA PACIFIC: MRI SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 134
TABLE 78 ASIA PACIFIC: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 135
TABLE 79 ASIA PACIFIC: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2024–2031 (USD MILLION) 135
TABLE 80 ASIA PACIFIC: MRI SYSTEMS MARKET, BY DESIGN, 2024–2031 (USD MILLION) 135
TABLE 81 ASIA PACIFIC: MRI SYSTEMS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 136
TABLE 82 ASIA PACIFIC: MRI SYSTEMS MARKET, BY END USER, 2024–2031 (USD MILLION) 136
TABLE 83 JAPAN: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024–2031 (USD MILLION) 137
TABLE 84 CHINA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024–2031 (USD MILLION) 138
TABLE 85 INDIA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024–2031 (USD MILLION) 139
TABLE 86 AUSTRALIA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 139
TABLE 87 SOUTH KOREA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 140
TABLE 88 REST OF ASIA PACIFIC: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 141
TABLE 89 LATIN AMERICA: MRI SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 141
TABLE 90 LATIN AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 142
TABLE 91 LATIN AMERICA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2024–2031 (USD MILLION) 142
TABLE 92 LATIN AMERICA: MRI SYSTEMS MARKET, BY DESIGN, 2024–2031 (USD MILLION) 142
TABLE 93 LATIN AMERICA: MRI SYSTEMS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 143
TABLE 94 LATIN AMERICA: MRI SYSTEMS MARKET, BY END USER,
2024–2031 (USD MILLION) 143
TABLE 95 BRAZIL: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024–2031 (USD MILLION) 144
TABLE 96 MEXICO: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 145
TABLE 97 REST OF LATIN AMERICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 145
TABLE 98 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 146
TABLE 99 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 146
TABLE 100 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY ARCHITECTURE,
2024–2031 (USD MILLION) 147
TABLE 101 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY DESIGN,
2024–2031 (USD MILLION) 147
TABLE 102 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 147
TABLE 103 MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY END USER,
2024–2031 (USD MILLION) 148
TABLE 104 GCC COUNTRIES: MRI SYSTEMS MARKET, BY FIELD STRENGTH,
2024–2031 (USD MILLION) 149
TABLE 105 REST OF MIDDLE EAST & AFRICA: MRI SYSTEMS MARKET, BY FIELD STRENGTH, 2024–2031 (USD MILLION) 149
TABLE 106 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN MRI SYSTEMS MARKET, 2023–2026 151
TABLE 107 MRI SYSTEMS MARKET: DEGREE OF COMPETITION 154
TABLE 108 MRI SYSTEMS MARKET: REGION FOOTPRINT 161
TABLE 109 MRI SYSTEMS MARKET: FIELD STRENGTH FOOTPRINT 161
TABLE 110 MRI SYSTEMS MARKET: APPLICATION FOOTPRINT 162
TABLE 111 MRI SYSTEMS MARKET: END USER FOOTPRINT 163
TABLE 112 MRI SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 166
TABLE 113 MRI SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 167
TABLE 114 MRI SYSTEMS MARKET: PRODUCT LAUNCHES, JANUARY 2023– MAY 2026 168
TABLE 115 MRI SYSTEMS MARKET: DEALS, JANUARY 2023– MAY 2026 169
TABLE 116 MRI SYSTEMS MARKET: EXPANSIONS, JANUARY 2023– MAY 2026 170
TABLE 117 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 171
TABLE 118 SIEMENS HEALTHINEERS: PRODUCTS OFFERED 172
TABLE 119 SIEMENS HEALTHINEERS: PRODUCT LAUNCHES 173
TABLE 120 SIEMENS HEALTHINEERS: DEALS 174
TABLE 121 SIEMENS HEALTHINEERS: EXPANSIONS 175
TABLE 122 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 176
TABLE 123 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 177
TABLE 124 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES 178
TABLE 125 KONINKLIJKE PHILIPS N.V.: DEALS 178
TABLE 126 KONINKLIJKE PHILIPS N.V.: EXPANSIONS 179
TABLE 127 GE HEALTHCARE: COMPANY OVERVIEW 180
TABLE 128 GE HEALTHCARE: PRODUCTS OFFERED 181
TABLE 129 GE HEALTHCARE: PRODUCT LAUNCHES 182
TABLE 130 GE HEALTHCARE: DEALS 182
TABLE 131 GE HEALTHCARE: EXPANSIONS 183
TABLE 132 CANON MEDICAL SYSTEMS: COMPANY OVERVIEW 184
TABLE 133 CANON MEDICAL SYSTEMS: PRODUCTS OFFERED 185
TABLE 134 CANON MEDICAL SYSTEMS: PRODUCT LAUNCHES 186
TABLE 135 CANON MEDICAL SYSTEMS: DEALS 186
TABLE 136 FUJIFILM CORPORATION: COMPANY OVERVIEW 188
TABLE 137 FUJIFILM CORPORATION: PRODUCTS OFFERED 189
TABLE 138 FUJIFILM CORPORATION: PRODUCT LAUNCHES 190
TABLE 139 FUJIFILM CORPORATION: DEALS 190
TABLE 140 FONAR CORPORATION: COMPANY OVERVIEW 192
TABLE 141 FONAR CORPORATION: PRODUCTS OFFERED 193
TABLE 142 FONAR CORPORATION: DEALS 193
TABLE 143 ESAOTE SPA: COMPANY OVERVIEW 194
TABLE 144 ESAOTE SPA: PRODUCTS OFFERED 194
TABLE 145 ESAOTE SPA: PRODUCT LAUNCHES 195
TABLE 146 ESAOTE SPA: DEALS 195
TABLE 147 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW 196
TABLE 148 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCTS OFFERED 197
TABLE 149 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–MAY 2026 197
TABLE 150 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: DEALS,
JANUARY 2023–MAY 2026 198
TABLE 151 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: EXPANSIONS 198
TABLE 152 ASPECT IMAGING LTD.: COMPANY OVERVIEW 199
TABLE 153 ASPECT IMAGING LTD.: PRODUCTS OFFERED 199
TABLE 154 TIME MEDICAL HOLDING: COMPANY OVERVIEW 200
TABLE 155 TIME MEDICAL HOLDING: PRODUCTS OFFERED 200
TABLE 156 TIME MEDICAL HOLDING: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2023–MAY 2026 201
TABLE 157 TIME MEDICAL HOLDING: EXPANSIONS, JANUARY 2023–MAY 2026 201
TABLE 158 NEUSOFT MEDICAL SYSTEMS CO., LTD. : COMPANY OVERVIEW 202
TABLE 159 NEUSOFT MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED 202
TABLE 160 NEUSOFT MEDICAL SYSTEMS CO., LTD.: DEALS, JANUARY 2023–MAY 2026 202
TABLE 161 STERNMED GMBH: COMPANY OVERVIEW 203
TABLE 162 STERNMED GMBH: PRODUCTS OFFERED 203
TABLE 163 STERNMED GMBH: DEALS, JANUARY 2023–MAY 2026 203
TABLE 164 HYPERFINE, INC.: COMPANY OVERVIEW 204
TABLE 165 HYPERFINE, INC.: PRODUCTS OFFERED 205
TABLE 166 HYPERFINE, INC.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2023–MAY 2026 205
TABLE 167 HYPERFINE, INC.: DEALS, JANUARY 2023–MAY 2026 205
TABLE 168 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.: COMPANY OVERVIEW 206
TABLE 169 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.: PRODUCTS OFFERED 206
TABLE 170 SHENZHEN ANKE HIGH-TECH., LTD.: COMPANY OVERVIEW 207
TABLE 171 SHENZHEN ANKE HIGH-TECH., LTD: PRODUCTS OFFERED 207
TABLE 172 MAGNETICA LTD: COMPANY OVERVIEW 208
TABLE 173 AURORA HEALTHCARE US CORP: COMPANY OVERVIEW 209
TABLE 174 INNERVISION MRI LTD.: COMPANY OVERVIEW 210
TABLE 175 BEIJING WANDONG MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 211
TABLE 176 MEDONICA CO., LTD: COMPANY OVERVIEW 212
TABLE 177 NEOSCAN SOLUTIONS GMBH: COMPANY OVERVIEW 212
TABLE 178 KANGDA INTERCONTINENTAL MEDICAL EQUIPMENT CO., LTD.:
COMPANY OVERVIEW 213
TABLE 179 MINFOUND MEDICAL SYSTEMS CO., LTD.: COMPANY OVERVIEW 214
TABLE 180 SYNAPTIVE MEDICAL: COMPANY OVERVIEW 215
TABLE 181 XINGAOYI MEDICAL EQUIPMENT CO,. LTD: COMPANY OVERVIEW 215
TABLE 182 MRI SYSTEMS MARKET: RESEARCH ASSUMPTIONS 230
TABLE 183 MRI SYSTEMS MARKET: RISK ANALYSIS 231
FIGURE 1 MARKET SCENARIO 29
FIGURE 2 GLOBAL MRI SYSTEMS MARKET, 2024–2031 29
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MRI SYSTEMS MARKET,
2024–2025 30
FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF MRI SYSTEMS MARKET 31
FIGURE 5 HIGH-GROWTH SEGMENTS IN MRI SYSTEMS MARKET, 2026–2031 32
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN MRI SYSTEMS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 33
FIGURE 7 GROWING BURDEN OF CHRONIC AND AGE RELATED DISEASES TO DRIVE MARKET 34
FIGURE 8 CHINA AND JAPAN TO HOLD MAJOR SHARE IN ASIA PACIFIC MARKET IN 2025 35
FIGURE 9 CHINA TO REGISTER HIGHEST CAGR FROM 2026 TO 2031 36
FIGURE 10 MRI SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 37
FIGURE 11 MRI SYSTEMS MARKET: PORTER’S FIVE FORCES ANALYSIS 46
FIGURE 12 MRI SYSTEMS MARKET: SUPPLY CHAIN ANALYSIS 49
FIGURE 13 MRI SYSTEMS MARKET: VALUE CHAIN ANALYSIS 50
FIGURE 14 MRI SYSTEMS MARKET: ECOSYSTEM ANALYSIS 51
FIGURE 15 AVERAGE SELLING PRICE TREND OF MRI SYSTEMS, BY KEY PLAYER,
2023–2025 (USD MILLION) 53
FIGURE 16 AVERAGE SELLING PRICE TREND OF MRI SYSTEMS, BY REGION,
2023–2025 (USD MILLION) 54
FIGURE 17 IMPORT SCENARIO FOR MRI SYSTEMS (HS CODE 901813) (USD THOUSAND) 56
FIGURE 18 IMPORT SCENARIO FOR MRI SYSTEMS (HS CODE 901813) (USD THOUSAND) 57
FIGURE 19 MRI SYSTEMS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 59
FIGURE 20 MRI SYSTEMS MARKET: INVESTMENT AND FUNDING SCENARIO, 2019–2023 59
FIGURE 21 MRI SYSTEMS MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER,
2019–2023 60
FIGURE 22 MRI SYSTEMS MARKET: VALUE OF INVESTOR DEALS, BY KEY PLAYER,
2019–2023 (USD MILLION) 60
FIGURE 23 PATENTS APPLIED AND GRANTED, 2015–2025 67
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 84
FIGURE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS 85
FIGURE 26 NORTH AMERICA: MRI SYSTEMS MARKET SNAPSHOT 122
FIGURE 27 ASIA PACIFIC: MRI SYSTEMS MARKET SNAPSHOT 134
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN MRI SYSTEMS MARKET,
2021–2025 (USD MILLION) 153
FIGURE 29 SHARE ANALYSIS OF KEY PLAYERS IN MRI SYSTEMS MARKET, 2025 153
FIGURE 30 RANKING OF KEY PLAYERS IN MRI SYSTEMS MARKET, 2025 155
FIGURE 31 EV/EBITDA OF TOP THREE PLAYERS (2026) 156
FIGURE 32 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF
TOP THREE PLAYERS (2026) 156
FIGURE 33 MRI SYSTEMS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 157
FIGURE 34 MRI SYSTEMS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 159
FIGURE 35 COMPANY FOOTPRINT 160
FIGURE 36 MRI SYSTEMS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 165
FIGURE 37 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2025) 172
FIGURE 38 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 177
FIGURE 39 GE HEALTHCARE: COMPANY SNAPSHOT (2025) 181
FIGURE 40 CANON MEDICAL SYSTEMS: COMPANY SNAPSHOT (2025) 185
FIGURE 41 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2025) 189
FIGURE 42 FONAR CORPORATION: COMPANY SNAPSHOT (2025) 192
FIGURE 43 SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY SNAPSHOT (2025) 196
FIGURE 44 HYPERFINE, INC.: COMPANY SNAPSHOT (2024) 204
FIGURE 45 MRI SYSTEMS MARKET: RESEARCH DATA 216
FIGURE 46 MRI SYSTEMS MARKET: RESEARCH DESIGN 217
FIGURE 47 MRI SYSTEMS MARKET: KEY SECONDARY SOURCES 218
FIGURE 48 MRI SYSTEMS MARKET: KEY DATA FROM SECONDARY SOURCES 218
FIGURE 49 MRI SYSTEMS MARKET: KEY PRIMARY SOURCES (DEMAND AND SUPPLY SIDES) 220
FIGURE 50 MRI SYSTEMS MARKET: KEY SUPPLY- AND DEMAND-SIDE PARTICIPANTS 220
FIGURE 51 MRI SYSTEMS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
(BY COMPANY TYPE, DESIGNATION, AND REGION) 221
FIGURE 52 MRI SYSTEMS MARKET: KEY INSIGHTS FROM PRIMARY EXPERTS 222
FIGURE 53 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 223
FIGURE 54 MRI SYSTEMS MARKET: COMPANY REVENUE ESTIMATION 224
FIGURE 55 MRI SYSTEMS MARKET: END USER AND REVENUE MAPPING-BASED MARKET SIZE ESTIMATION METHODOLOGY 225
FIGURE 56 MRI SYSTEMS MARKET: TOP-DOWN APPROACH 226
FIGURE 57 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACRO INDICATORS 228
FIGURE 58 MRI SYSTEMS MARKET: DATA TRIANGULATION METHODOLOGY 229